Biogen Chief Sees Biosimilars as ‘Meaningful Revenue Stream’

Biogen Idec Inc., the world’s largest maker of multiple sclerosis drugs, plans to expand into biogenerics, Chief Executive Officer George Scangos said today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.